Evidence map›Paper›PMID 28422752›Full record

ArticleJCI insight2017

T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.

James J Knox, Marcus Buggert, Lela Kardava, Kelly E Seaton, Michael A Eller, David H Canaday, Merlin L Robb, Mario A Ostrowski, Steven G Deeks, Mark K Slifka and 4 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 180 citations in OpenAlex.

  1. Elevated CD21Journal of clinical immunology · 2022
    Trial
  2. Trial
  3. Trial
  4. The Antigen Presenting Potential of CD21Frontiers in immunology · 2020
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Human CD21Journal of human immunity · 2026
    Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. The multilayered identity of B cell memory.Cellular & molecular immunology · 2026
    Review
  17. Article
  18. Article
  19. Immunoglobulin G in aging and cancer.Frontiers in immunology · 2026
    Review
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

James J KnoxDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Marcus BuggertDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lela KardavaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Kelly E SeatonDuke Human Vaccine Institute; and Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Michael A EllerUS Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
David H CanadayDivision of Infectious Disease, Case Western Reserve University School of Medicine, and Cleveland VA, Cleveland, Ohio, USA.
Merlin L RobbUS Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Mario A OstrowskiDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Ontario, Canada.
Steven G DeeksDepartment of Medicine, University of California, San Francisco, San Francisco, California, USA.
Mark K SlifkaDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA.
Georgia D TomarasDuke Human Vaccine Institute; and Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Susan MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
M Anthony MoodyDuke Human Vaccine Institute; Department of Pediatrics; and Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Michael R BettsDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
International Vaccine Institute · KRHenry M. Jackson Foundation · USNational Institute of Allergy and Infectious Diseases · USUniversity of Pennsylvania · USCase Western Reserve University · USKarolinska University Hospital · SEOregon National Primate Research Center · USSt. Michael's Hospital · CAUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Role of B Lymphocytes In HIV Infection And PathogenesisZIAAI000825 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOIR, SUSAN · 2009 to 2025
$24.5M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
T cell functionality and control of HIV infectionR01AI076066 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2008 to 2017
$4.6M
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI076066NIAID NIH HHS T32 AI007632
6 · The paper itself

Abstract

Humoral immunity is critical for viral control, but the identity and mechanisms regulating human antiviral B cells are unclear. Here, we characterized human B cells expressing T-bet and analyzed their dynamics during viral infections. T-bet+ B cells demonstrated an activated phenotype, a distinct transcriptional profile, and were enriched for expression of the antiviral immunoglobulin isotypes IgG1 and IgG3. T-bet+ B cells expanded following yellow fever virus and vaccinia virus vaccinations and also during early acute HIV infection. Viremic HIV-infected individuals maintained a large T-bet+ B cell population during chronic infection that was associated with increased serum and cell-associated IgG1 and IgG3 expression. The HIV gp140-specific B cell response was dominated by T-bet-expressing memory B cells, and we observed a concomitant biasing of gp140-specific serum immunoglobulin to the IgG1 isotype. These findings suggest that T-bet induction promotes antiviral immunoglobulin isotype switching and development of a distinct T-bet+ B cell subset that is maintained by viremia and coordinates the HIV Env-specific humoral response.

Indexed as

AIDS/HIVImmunology

Identifiers

PMID28422752
PMCPMC5396521
OpenAlexW2606922555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.